Company profilePharmaceutical#219 of 1,318 in Pakistan1 DRAP alert

Health care pharmaceuticals

Pharmaceutical company · 81 brands · 67 molecules

Ranked #261 of 311 companies in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord)

81 registered products 39 pharmaceutical brands 67 distinct molecules 1 DRAP alert

Company overview

81
registered products
39
pharmaceutical brands
67
distinct molecules
1
therapeutic classes
1
DRAP alerts

Health care pharmaceuticals is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 81 product registrations across 67 distinct molecules. Its portfolio is concentrated in Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by Health

68 products matched in our catalogue — each with its observed price and DRAP approved ceiling.

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) 2

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

68
ceilings with an approval date
0
not revised in 2+ years
2025
oldest approval year
202568

Top molecules by brand count

Ceftriaxone7 brands
Azithromycin4 brands
Paracetamol4 brands
Linezolid4 brands
Cefixime3 brands
Clopidogrel3 brands
Permethrin3 brands

Therapeutic classes

Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official99 products · Rs 62.91 – Rs 4,497.69
Median across source: Rs 334.58

Regulatory record

1 alert in the DRAP feed we track.

Drug Product Recall: Practel Paediatric Oral Suspension (Batch# AA008) by M/s Health Care
2021-12-08

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Global Pharmaceuticals Pakistan holds 120 molecules not in this portfolio
AmikacinAmlodipineAmocycillinAmoxicillinAmoxicillin AmoxicillintrihydrateAmoxycillin
MEDIATE PHARMACEUTICALS (PVT) LTD holds 93 molecules not in this portfolio
AcyclovirAlendronateAmlodipineAmoxicillinAmpicillinAmpicillin Base
SHAIGAN PHARMACEUTICALS (PVT) LTD. holds 120 molecules not in this portfolio
AlbendazoleAmikacinAmlodipineAmlodipine BasylateAscorbic AcidAspirin

Get the full profile for Health

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.